Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Multi-center, Randomized, Controlled, Single-blind Study of the Safety and Effectiveness of Algeness® DF 3.5% Deep Volumizing Filler to Correct Age-related Volume Deficit in the Mid-face

NCT04892407 is registered in ClinicalTrials.gov with Advanced Aesthetic Technologies, Inc as lead sponsor.

NCT NCT04892407
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04892407 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Multi-center, Randomized, Controlled, Single-blind Study of the Safety and Effectiveness of Algeness® DF 3.5% Deep Volumizing Filler to Correct Age-related Volume Deficit in the Mid-face
Lead sponsor
Advanced Aesthetic Technologies, Inc
Phase
Not applicable
Overall status
Unknown status
Start date
September 6, 2021
Completion date
August 31, 2024
Enrollment
308 (estimated)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

age-related volume deficit in the mid-face